Intravenous (IV) single dose

DRUG2 trials

Sponsors

GlaxoSmithKline, C Ray Therapeutics

Conditions

AsthmaProstate Cancer

Phase 1

A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

CompletedNCT01563042

GlaxoSmithKlineAsthma

Start: 2012-02-13End: 2012-05-23Updated: 2017-06-20

Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer

Active, not recruitingNCT07236112

C Ray TherapeuticsProstate Cancer

Start: 2026-02-08End: 2026-07-31Target: 6Updated: 2026-04-15